Kimberly Williams
About Kimberly Williams
Kimberly Williams is the Executive Director of Strategic Alliance and Issue Advocacy at Bristol Myers Squibb, with over two decades of experience in federal government relations and public affairs.
Current Role at Bristol Myers Squibb
Kimberly Williams serves as the Executive Director of Strategic Alliance and Issue Advocacy at Bristol Myers Squibb. She is based in Washington, D.C., a pivotal location for government affairs and policy advocacy. Since joining the company in mid-2022, Kimberly continues to leverage her extensive background in federal government relations and public affairs. Her role focuses on developing strategic alliances and advocating for policy issues critical to the pharmaceutical industry.
Previous Tenure at Novo Nordisk
Before her current role, Kimberly Williams worked at Novo Nordisk. She was the Director of Public Affairs and Alliance Development from 2020 to 2022. During her tenure at Novo Nordisk, she focused on building strategic alliances and advancing public health policies. Her experience at Novo Nordisk added to her robust expertise in the pharmaceutical sector's public affairs.
Long-Term Role at GSK
Kimberly Williams spent 21 years at GSK, where she held the position of Senior Director of Federal Government Relations. Her tenure at GSK, from 1999 to 2020, involved engaging with federal stakeholders and promoting government relations strategies. This long-term role enabled her to gain profound insights into federal policies and build a strong network within the pharmaceutical industry.
Expertise in Federal Government Relations
With over two decades of experience in federal government relations and public affairs, Kimberly Williams has established herself as a seasoned professional in the pharmaceutical field. Her roles have consistently involved alliance development and issue advocacy, showcasing her capability to navigate complex regulatory landscapes and build strategic partnerships.
Location and Strategic Impact
Based in Washington, D.C., Kimberly Williams operates in a key hub for government affairs and policy advocacy. Her location allows her to effectively engage with policymakers and advocate for industry-wide issues. This strategic positioning enhances her ability to influence policy decisions and advance the interests of the pharmaceutical companies she represents.